Correlation Between Silverback Therapeutics and Ovid Therapeutics
Can any of the company-specific risk be diversified away by investing in both Silverback Therapeutics and Ovid Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silverback Therapeutics and Ovid Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Silverback Therapeutics and Ovid Therapeutics, you can compare the effects of market volatilities on Silverback Therapeutics and Ovid Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silverback Therapeutics with a short position of Ovid Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silverback Therapeutics and Ovid Therapeutics.
Diversification Opportunities for Silverback Therapeutics and Ovid Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Silverback and Ovid is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Silverback Therapeutics and Ovid Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ovid Therapeutics and Silverback Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silverback Therapeutics are associated (or correlated) with Ovid Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ovid Therapeutics has no effect on the direction of Silverback Therapeutics i.e., Silverback Therapeutics and Ovid Therapeutics go up and down completely randomly.
Pair Corralation between Silverback Therapeutics and Ovid Therapeutics
Given the investment horizon of 90 days Silverback Therapeutics is expected to generate 0.7 times more return on investment than Ovid Therapeutics. However, Silverback Therapeutics is 1.43 times less risky than Ovid Therapeutics. It trades about 0.29 of its potential returns per unit of risk. Ovid Therapeutics is currently generating about -0.4 per unit of risk. If you would invest 1,120 in Silverback Therapeutics on October 23, 2024 and sell it today you would earn a total of 137.00 from holding Silverback Therapeutics or generate 12.23% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Silverback Therapeutics vs. Ovid Therapeutics
Performance |
| Timeline |
| Silverback Therapeutics |
| Ovid Therapeutics |
Silverback Therapeutics and Ovid Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Silverback Therapeutics and Ovid Therapeutics
The main advantage of trading using opposite Silverback Therapeutics and Ovid Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silverback Therapeutics position performs unexpectedly, Ovid Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ovid Therapeutics will offset losses from the drop in Ovid Therapeutics' long position.| Silverback Therapeutics vs. Nuvalent | Silverback Therapeutics vs. Arcellx | Silverback Therapeutics vs. Vaxcyte | Silverback Therapeutics vs. Crinetics Pharmaceuticals |
| Ovid Therapeutics vs. CytomX Therapeutics | Ovid Therapeutics vs. Spero Therapeutics | Ovid Therapeutics vs. Instil Bio | Ovid Therapeutics vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |